Preprint: Molecular evidence for SARS-CoV-2 in samples collected since late summer 2019 in Lombardy

Asia, China, Coronavirus, Europe, Health, Hospitalization, Infection, Italy, Origins, Symptoms, Testing, Transmission, Variants

435 samples from 156 cases were investigated.  RNA isolated from oropharyngeal swabs and urine was screened by hemi-nested PCRs targeting key sites for viral typing. Molecular evidence for SARS-CoV-2 infection was found in 13 subjects. Two patients were from the pandemic period (2/12, 16·7%, March 2020-March 2021) and 11 were from the pre-pandemic period (11/44, 25%, August 2019-February 2020).

Five of the positive individuals showed the simultaneous presence of anti-SARS-CoV-2 antibodies. No clear evidence of infection was found in 281 samples collected between August 2018 and July 2019 from 100 patients. The first positivity for SARS-CoV-2 RNA was found in a sample collected on September 12, 2019. Mutations typical of B.1 (PANGOLIN classification) strains, previously reported to have emerged in January 2020, had already been circulating in October 2019. Hence, we estimate SARS-CoV-2 progenitor of known human infections to have emerged in late June-late August 2019.

Preprint: Molecular Evidence for SARS-CoV-2 in Samples Collected From Patients With Morbilliform Eruptions Since Late Summer 2019 in Lombardy, Northern Italy

 

 

Italy: WHO retests patient samples from September 2019 that tested positive for SARS-CoV-2 RBD-specific antibodies

 

 

Image by Tommy_Rau from Pixabay